Trulieve Cannabis (TSE:TRU) Upgraded to Moderate Buy at Cormark

Cormark upgraded shares of Trulieve Cannabis (TSE:TRU) from a hold rating to a moderate buy rating in a research report sent to investors on Monday,Zacks.com reports.

TRU has been the topic of several other research reports. Craig Hallum raised Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th. Atb Cap Markets upgraded shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th.

Trulieve Cannabis Price Performance

Insider Buying and Selling

In related news, Senior Officer Wes Getman acquired 9,500 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average price of C$7.02 per share, for a total transaction of C$66,702.35.

Trulieve Cannabis Company Profile

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.